1. Home
  2. BTOC vs PHIO Comparison

BTOC vs PHIO Comparison

Compare BTOC & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTOC

Armlogi Holding Corp.

HOLD

Current Price

$0.28

Market Cap

12.9M

Sector

N/A

ML Signal

HOLD

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

HOLD

Current Price

$1.07

Market Cap

13.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTOC
PHIO
Founded
2020
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9M
13.1M
IPO Year
2023
2011

Fundamental Metrics

Financial Performance
Metric
BTOC
PHIO
Price
$0.28
$1.07
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$2.00
$14.00
AVG Volume (30 Days)
196.1K
126.9K
Earning Date
05-24-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$190,408,258.00
N/A
Revenue This Year
$34.89
N/A
Revenue Next Year
$14.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.03
N/A
52 Week Low
$0.23
$0.81
52 Week High
$1.78
$4.19

Technical Indicators

Market Signals
Indicator
BTOC
PHIO
Relative Strength Index (RSI) 47.54 37.89
Support Level $0.27 $1.00
Resistance Level $0.34 $1.21
Average True Range (ATR) 0.02 0.05
MACD -0.00 -0.01
Stochastic Oscillator 21.44 15.79

Price Performance

Historical Comparison
BTOC
PHIO

About BTOC Armlogi Holding Corp.

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

Share on Social Networks: